Treatment for metastatic hormone refractory prostate cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy3

Cell Line, Tumor Prostate Tumor Cells, Cultured

Organisms1

Diseases18

Prostatic Neoplasms Neoplasms, Hormone-Dependent Bone Neoplasms Prostatic Hyperplasia Disease Progression Neoplasm Metastasis Adenocarcinoma Prostatic Intraepithelial Neoplasia Neoplasm Invasiveness Genetic Predisposition to Disease Breast Neoplasms Neoplasms Anemia, Refractory Neoplasm Recurrence, Local Carcinoma Lung Neoplasms Ovarian Neoplasms Prostatic Neoplasms, Castration-Resistant

Chemicals and Drugs32

Estramustine Prostate-Specific Antigen Androgen Antagonists Receptors, Androgen Strontium Radioisotopes Taxoids Antineoplastic Agents, Hormonal Formazans Androgens Hormones Thyroid Hormones Tumor Markers, Biological Follicle Stimulating Hormone Antineoplastic Agents Gonadotropin-Releasing Hormone Luteinizing Hormone Tosyl Compounds Gonadal Steroid Hormones RNA, Messenger Parathyroid Hormone Androgen Receptor Antagonists Neoplasm Proteins Dihydrotestosterone Anilides Testosterone Finasteride Metribolone Flutamide RNA, Small Interfering Receptors, Thyroid Hormone Human Growth Hormone Anticarcinogenic Agents

Analytical, Diagnostic and Therapeutic Techniques and Equipment32

Prostatectomy Orchiectomy Early Detection of Cancer Neoplasm Staging Neoplasm Grading Treatment Outcome Reverse Transcriptase Polymerase Chain Reaction Prognosis Risk Factors Xenograft Model Antitumor Assays Immunohistochemistry Follow-Up Studies Digital Rectal Examination Neoplasm Transplantation Prospective Studies Blotting, Western Transplantation, Heterologous Case-Control Studies Retrospective Studies Gene Expression Profiling Survival Analysis Survival Rate Antineoplastic Combined Chemotherapy Protocols Risk Risk Assessment Transurethral Resection of Prostate Biopsy Sensitivity and Specificity Disease-Free Survival Castration Transfection Combined Modality Therapy

Phenomena and Processes17

Drug Resistance, Neoplasm Gene Expression Regulation, Neoplastic Cell Proliferation Apoptosis Genetic Predisposition to Disease Signal Transduction Time Factors Refractory Period, Electrophysiological Dose-Response Relationship, Drug Risk Cell Division Down-Regulation Cell Growth Processes Genotype Sensitivity and Specificity Cell Survival Transfection

Disciplines and Occupations1

Immunohistochemistry

Information Science1

Health Care13

Treatment Outcome Risk Factors Follow-Up Studies Prospective Studies Watchful Waiting Case-Control Studies Retrospective Studies Survival Analysis Survival Rate Risk Risk Assessment Sensitivity and Specificity Disease-Free Survival

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care Geographicals

Prostatic Neoplasms Estramustine Prostate-Specific Antigen Neoplasms, Hormone-Dependent Androgen Antagonists Receptors, Androgen Strontium Radioisotopes Taxoids Drug Resistance, Neoplasm Antineoplastic Agents, Hormonal Cell Line, Tumor Formazans Androgens Prostate Bone Neoplasms Gene Expression Regulation, Neoplastic Hormones Prostatectomy Prostatic Hyperplasia Orchiectomy Early Detection of Cancer Thyroid Hormones Disease Progression Tumor Markers, Biological Neoplasm Metastasis Mice, Nude Follicle Stimulating Hormone Adenocarcinoma Prostatic Intraepithelial Neoplasia Antineoplastic Agents Gonadotropin-Releasing Hormone Luteinizing Hormone Tosyl Compounds Gonadal Steroid Hormones Neoplasm Invasiveness Cell Proliferation Neoplasm Staging RNA, Messenger Tumor Cells, Cultured Neoplasm Grading Treatment Outcome Apoptosis Reverse Transcriptase Polymerase Chain Reaction Prognosis Parathyroid Hormone Genetic Predisposition to Disease Androgen Receptor Antagonists Risk Factors Neoplasm Proteins Breast Neoplasms Xenograft Model Antitumor Assays Dihydrotestosterone Anilides Neoplasms Signal Transduction Immunohistochemistry Follow-Up Studies Testosterone Digital Rectal Examination Anemia, Refractory Neoplasm Transplantation Prospective Studies Neoplasm Recurrence, Local Blotting, Western Watchful Waiting Transplantation, Heterologous Case-Control Studies Retrospective Studies Time Factors Refractory Period, Electrophysiological Finasteride Gene Expression Profiling Dose-Response Relationship, Drug Survival Analysis Survival Rate Carcinoma Antineoplastic Combined Chemotherapy Protocols Lung Neoplasms Risk Metribolone Ovarian Neoplasms Flutamide Cell Division Down-Regulation Risk Assessment Transurethral Resection of Prostate Biopsy RNA, Small Interfering Cell Growth Processes Receptors, Thyroid Hormone Genotype Sensitivity and Specificity Human Growth Hormone Disease-Free Survival Castration Cell Survival Prostatic Neoplasms, Castration-Resistant Transfection United States Combined Modality Therapy

No FAQ available that match "treatment for metastatic hormone refractory prostate cancer"